389 related articles for article (PubMed ID: 19131916)
1. The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration.
El-Nahas M; Gawish H; Tarshoby M; State O
J Wound Care; 2009 Jan; 18(1):33-7. PubMed ID: 19131916
[TBL] [Abstract][Full Text] [Related]
2. The impact of topical phenytoin loaded nanostructured lipid carriers in diabetic foot ulceration.
Motawea A; Abd El-Gawad AEH; Borg T; Motawea M; Tarshoby M
Foot (Edinb); 2019 Sep; 40():14-21. PubMed ID: 30999080
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
[TBL] [Abstract][Full Text] [Related]
4. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
[TBL] [Abstract][Full Text] [Related]
6. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
[TBL] [Abstract][Full Text] [Related]
7. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
Buzzi M; de Freitas F; Winter M
Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
[TBL] [Abstract][Full Text] [Related]
8. The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial.
Shaw J; Hughes CM; Lagan KM; Stevenson MR; Irwin CR; Bell PM
Diabet Med; 2011 Oct; 28(10):1154-7. PubMed ID: 21480976
[TBL] [Abstract][Full Text] [Related]
9. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.
Zimny S; Schatz H; Pfohl M
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323
[TBL] [Abstract][Full Text] [Related]
10. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
[TBL] [Abstract][Full Text] [Related]
11. Topical phenytoin for wound healing.
Bhatia A; Prakash S
Dermatol Online J; 2004 Jul; 10(1):5. PubMed ID: 15347487
[TBL] [Abstract][Full Text] [Related]
12. The use of topical phenytoin for healing of chronic venous ulcerations.
Hokkam E; El-Labban G; Shams M; Rifaat S; El-Mezaien M
Int J Surg; 2011; 9(4):335-8. PubMed ID: 21338720
[TBL] [Abstract][Full Text] [Related]
13. Topical and biologic therapies for diabetic foot ulcers.
Richmond NA; Vivas AC; Kirsner RS
Med Clin North Am; 2013 Sep; 97(5):883-98. PubMed ID: 23992899
[TBL] [Abstract][Full Text] [Related]
14. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
Henshaw FR; Bolton T; Nube V; Hood A; Veldhoen D; Pfrunder L; McKew GL; Macleod C; McLennan SV; Twigg SM
J Diabetes Complications; 2014; 28(6):850-7. PubMed ID: 25239451
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study.
Tallis A; Motley TA; Wunderlich RP; Dickerson JE; Waycaster C; Slade HB;
Clin Ther; 2013 Nov; 35(11):1805-20. PubMed ID: 24145042
[TBL] [Abstract][Full Text] [Related]
16. The effects of applied felted foam on wound healing and healing times in the therapy of neuropathic diabetic foot ulcers.
Zimny S; Schatz H; Pfohl U
Diabet Med; 2003 Aug; 20(8):622-5. PubMed ID: 12873288
[TBL] [Abstract][Full Text] [Related]
17. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
[TBL] [Abstract][Full Text] [Related]
18. Management of diabetic foot ulcers with a TLC-NOSF wound dressing.
Richard JL; Martini J; Bonello Faraill MM; Bemba JM; Lepeut M; Truchetet F; Ehrler S; Schuldiner S; Sauvadet A; Bohbot S
J Wound Care; 2012 Mar; 21(3):142-7. PubMed ID: 22399083
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of WF10 adjunct to standard treatment of diabetic foot ulcers.
Yingsakmongkol N
J Wound Care; 2013 Mar; 22(3):130-2, 134-6. PubMed ID: 23665731
[TBL] [Abstract][Full Text] [Related]
20. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
